Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M6,042Revenue (TTM) $M1,296Net Margin (%)9.2Altman Z-Score3.5
Enterprise Value $M6,641EPS (TTM) $0.5Operating Margin %11.3Piotroski F-Score6
P/E(ttm)53.3Beneish M-Score-2.7Pre-tax Margin (%)8.9Higher ROA y-yY
Price/Book2.410-y EBITDA Growth Rate %5.8Quick Ratio3.1Cash flow > EarningsY
Price/Sales4.75-y EBITDA Growth Rate %5.1Current Ratio3.6Lower Leverage y-yY
Price/Free Cash Flow27.9y-y EBITDA Growth Rate %15.9ROA % (ttm)2.9Higher Current Ratio y-yY
Dividend Yield %--PEG10.5ROE % (ttm)4.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M234ROIC % (ttm)4.7Gross Margin Increase y-yN

Gurus Latest Trades with QGEN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
QGENGeorge Soros 2016-06-30 Sold Out -0.05%$20.19 - $24.05
$ 25.8117%Sold Out0
QGENGeorge Soros 2016-03-31 Buy 0.05%$20.38 - $27.65
$ 25.8116%New holding78,400
QGENRon Baron 2014-03-31 Sold Out $20.46 - $24.82
$ 25.8115%Sold Out0
QGENRon Baron 2013-12-31 Reduce$20.63 - $24.65
$ 25.8115%Reduce -49.00%10,200
QGENRon Baron 2013-06-30 Reduce$18.45 - $21.08
$ 25.8132%Reduce -45.95%20,000
QGENRon Baron 2012-03-31 Add$14.49 - $16.76
$ 25.8179%Add 26.98%40,000
QGENRon Baron 2010-12-31 Add$17.02 - $19.92
$ 25.8138%Add 44.23%37,500
QGENRon Baron 2010-09-30 Buy $17.66 - $20.62
$ 25.8137%New holding26,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

QGEN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!

QGEN: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about QGEN :

Quarterly/Annual Reports about QGEN:

    News about QGEN:

    Articles On GuruFocus.com
    David Herro's Oakmark International Small Cap Fund 4th Quarter Commentary Jan 08 2016 
    Biotech Gets Personal: Long on Qiagen (QGEN) & SPDR S&P Biotech (XBI) Feb 29 2012 
    Guru Stocks at 52-Week Lows: LMT, VIP, VMC, IRM, QGEN Oct 10 2010 
    Weekly Guru Bargains Highlights: QGEN, BXS, ATHR, LYV, TFSL Oct 09 2010 

    More From Other Websites
    QIAGEN launches QIAscout for single-cell isolation Oct 20 2016
    QIAGEN Launches QIAscout for Single-cell Isolation Oct 20 2016
    ETF’s with exposure to QIAGEN NV : October 19, 2016 Oct 19 2016
    What IBM's Genomic Partnership With Quest Says About Thermo Fisher, Diagnostics Peers Oct 19 2016
    QIAGEN unveils unique Sample to Insight solutions for liquid biopsies and hereditary diseases Oct 17 2016
    QIAGEN Unveils Unique Sample to Insight Solutions for Liquid Biopsies and Hereditary Diseases Oct 17 2016
    QIAGEN's High-Throughput Solutions for Human ID Database Oct 13 2016
    QIAGEN NV breached its 50 day moving average in a Bearish Manner : QGEN-US : October 12, 2016 Oct 12 2016
    QIAGEN Launches QIAsymphony SP Device Outside the U.S. Oct 11 2016
    QIAGEN N.V. to Report Third Quarter and First Nine Months of 2016 Results Oct 11 2016
    QIAGEN launches high-throughput solutions for human ID databases Oct 10 2016
    QIAGEN Launches High-throughput Solutions for Human ID Databases Oct 10 2016
    QIAGEN Introduces QIAsymphony Sample Processing Option to GeneReader NGS Workflow for Non U.S.... Oct 05 2016
    QIAGEN and ICMP to develop first NGS workflow for identification of missing persons Sep 29 2016
    QIAGEN and ICMP to Develop First NGS Workflow for Identification of Missing Persons Sep 29 2016
    Qiagen: Molecular Diagnostics & Expansion Plans on Track Sep 16 2016
    QIAGEN comments on preliminary injunction and confirms intention to defend its U.S. intellectual... Sep 10 2016
    QIAGEN Comments on Preliminary Injunction and Confirms Intention to Defend its U.S. Intellectual... Sep 10 2016
    QIAGEN welcomes U.S. guidance for latent TB testing in primary care Sep 08 2016
    QIAGEN Welcomes U.S. Guidance for Latent TB Testing in Primary Care Sep 08 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)